AMG 357

DRUG2 trials

Sponsors

Amgen

Conditions

Inflammatory DiseaseRheumatoid Arthritis

Phase 1

A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), Food Effect of AMG 357 in Healthy Subjects

CompletedNCT01695876

AmgenInflammatory Disease

Start: 2012-10-31End: 2014-10-31Updated: 2015-03-04

Study to Evaluate the Safety, Tolerability, and Action of AMG 357 in Females With Rheumatoid Arthritis

TerminatedNCT02499315

AmgenRheumatoid Arthritis

Start: 2015-04-30End: 2016-02-29Target: 32Updated: 2016-05-06